TY - JOUR
T1 - Infections Up to 76 Days After Stroke Increase Disability and Death
AU - Learoyd, Annastazia E
AU - Woodhouse, Lisa
AU - Shaw, Laurence
AU - Sprigg, Nikola
AU - Bereczki, Daniel
AU - Berge, Eivind
AU - Caso, Valeria
AU - Christensen, Hanne
AU - Collins, Ronan
AU - Czlonkowska, Anna
AU - El Etribi, Anwar
AU - Farr, Tracy D
AU - Gommans, John
AU - Laska, Ann-Charlotte
AU - Ntaios, George
AU - Ozturk, Serefnur
AU - Pocock, Stuart J
AU - Prasad, Kameshwar
AU - Wardlaw, Joanna M
AU - Fone, Kevin C
AU - Bath, Philip M
AU - Trueman, Rebecca C
AU - ENOS Trial investigators
PY - 2017/12/1
Y1 - 2017/12/1
N2 - Early infection after stroke is associated with a poor outcome. We aimed to determine whether delayed infections (up to 76 days post-stroke) are associated with poor outcome at 90 days. Data came from the international Efficacy of Nitric Oxide Stroke (ENOS, ISRCTN99414122) trial. Post hoc data on infections were obtained from serious adverse events reports between 1 and 76 days following stroke in this large cohort of patients. Regression models accounting for baseline covariates were used to analyse fatalities and functional outcomes (modified Rankin Scale (mRS), Barthel Index, Euro-Qol-5D) at 90 days, in patients with infection compared to those without infection. Of 4011 patients, 242 (6.0%) developed one or more serious infections. Infections were associated with an increased risk of death (p < 0.001) and an increased likelihood of dependency (measured by mRS) compared to those of all other patients (p < 0.001). This remained when only surviving patients were analysed, indicating that the worsening of functional outcome is not due to mortality (p < 0.001). In addition, the timing of the infection after stroke did not alter its detrimental association with fatality (p = 0.14) or functional outcome (p = 0.47). In conclusion, severe post-stroke infections, whether occurring early or late after stroke, are associated with an increased risk of death and poorer functional outcome, independent of differences in baseline characteristics or treatment. Not only are strategies needed for reducing the risk of infection immediately after stroke, but also during the first 3 months following a stroke. This study is registered: ISRCTN registry, number ISRCTN99414122, ClinicalTrials.gov Identifier, NCT00989716.
AB - Early infection after stroke is associated with a poor outcome. We aimed to determine whether delayed infections (up to 76 days post-stroke) are associated with poor outcome at 90 days. Data came from the international Efficacy of Nitric Oxide Stroke (ENOS, ISRCTN99414122) trial. Post hoc data on infections were obtained from serious adverse events reports between 1 and 76 days following stroke in this large cohort of patients. Regression models accounting for baseline covariates were used to analyse fatalities and functional outcomes (modified Rankin Scale (mRS), Barthel Index, Euro-Qol-5D) at 90 days, in patients with infection compared to those without infection. Of 4011 patients, 242 (6.0%) developed one or more serious infections. Infections were associated with an increased risk of death (p < 0.001) and an increased likelihood of dependency (measured by mRS) compared to those of all other patients (p < 0.001). This remained when only surviving patients were analysed, indicating that the worsening of functional outcome is not due to mortality (p < 0.001). In addition, the timing of the infection after stroke did not alter its detrimental association with fatality (p = 0.14) or functional outcome (p = 0.47). In conclusion, severe post-stroke infections, whether occurring early or late after stroke, are associated with an increased risk of death and poorer functional outcome, independent of differences in baseline characteristics or treatment. Not only are strategies needed for reducing the risk of infection immediately after stroke, but also during the first 3 months following a stroke. This study is registered: ISRCTN registry, number ISRCTN99414122, ClinicalTrials.gov Identifier, NCT00989716.
U2 - 10.1007/s12975-017-0553-3
DO - 10.1007/s12975-017-0553-3
M3 - Journal article
C2 - 28752410
SN - 1868-4483
VL - 8
SP - 541
EP - 548
JO - Translational Stroke Research
JF - Translational Stroke Research
IS - 6
ER -